Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Remote exercise program after spontaneous coronary artery dissection

Official title: Exercise Support and Rehabilitation for Patients After Spontaneous Coronary Artery Dissection- a Feasibility Study

Run by University of Leicester · NCT06955663 · Data updated 2026-11-12

This study tests a remote exercise program to see if it’s doable for women recovering from SCAD events.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment120 (estimated)
SponsorUniversity of Leicester
Academic / other
Locations1 site (Leicester, Leicestershire)
StatusRecruiting
StartedMay 1, 2025
Main results expectedAugust 1, 2027
Study endsDecember 31, 2027
Registry record updatedMay 14, 2026
Trial IDNCT06955663 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult women (18+) with angiographically confirmed SCAD referred to the Leicester clinic, with preserved left ventricular function (EF >45%) and blood pressure within limits, who can access the internet via smartphone.

Probably not a fit

Patients with SCAD who cannot travel to Leicester, lack internet access, or have contraindications to exercise may not benefit from this remote approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to determine the feasibility of delivering a remote exercise rehabilitation program to women recovering from spontaneous coronary artery dissection (SCAD). It will enroll eligible participants who have SCAD confirmed by angiography and are referred to a regional clinic, and assess recruitment, adherence, safety, and usability of a home-based exercise approach. The program focuses on age-appropriate, gender-specific considerations since SCAD patients are often younger women, differing from traditional cardiac rehab populations. Results will inform whether a fully powered randomized trial is practical and how to optimize remote cardiac rehabilitation for this group.

Why it matters

Potential benefit: If successful, the remote program could provide a feasible path to safer, accessible exercise-based recovery for SCAD patients, potentially improving recovery confidence and physical function.

How similar studies have gone: Prior observational data suggested feasibility of exercise after SCAD, but there is limited randomized trial evidence; this study tests feasibility in a randomized or structured framework.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female
* Aged ≥18 years.
* Diagnosed with angiographically confirmed SCAD and referred to the Leicester SCAD clinic.
* Ejection fraction \>45%.
* Blood pressure \<180/100. Resting heart rate \<100bpm

Exclusion Criteria:

* No SCAD diagnosis.
* Unable to travel to Leicester Hospital for their SCAD clinic appointment.
* Unable to give informed consent.
* No smart phone or internet access
* Unable to understand verbal explanations in English.

Where it's running

  • University Hospitals of Leicester
    Leicester, Leicestershire, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: David Adlam, BA BM BCh DPhil FRCP FESC — University of Leicester
  • Study coordinator: Noemi Vadaszy, BSc, MSc, PhD
  • Email: nv96@leicester.ac.uk
  • Phone: + 44 116 258 3828

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.